Philipp Harter
KEM Essen | Evang. Kliniken Essen-Mitte gGmbH · Evangelische Kliniken Essen-Mitte, Germany · European Network of Gynaecological Oncological Trial Groups (ENGOT)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Philipp Harter as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:45 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05009082 · Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian CancerAGO Study Group · recruiting · Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer · study chair
- Ph2NCT04274426 · Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian CancerAGO Research GmbH · active not recruiting · Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma · study chair
- Ph3NCT03737643 · Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer PatientsAstraZeneca · active not recruiting · Advanced Ovarian Cancer · principal investigator
- N/ANCT03438474 · Endometrial Cancer Lymphadenectomy TrialPhilipps University Marburg · recruiting · Cancer of Endometrium Stage I, Cancer of Endometrium Stage II · principal investigator
- Ph3NCT03353831 · Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian CancerAGO Research GmbH · completed · Recurrent Ovarian Carcinoma · study chair
- N/ANCT02222883 · Prevalence of BRCA in Patients With Ovarian CancerAGO Research GmbH · completed · BRCA Status, Ovarian Cancer · study chair
- N/ANCT01166737 · Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian CancerAGO Study Group · completed · Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer · principal investigator
- Ph2NCT00815945 · Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal TumorsAGO Study Group · completed · Mesenchymal Tumor, Carcinosarcoma, Leiomyosarcoma · principal investigator
- N/ANCT00368420 · Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian CancerAGO Study Group · completed · Ovarian Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:45 UTC. The ranking covers the 200 most relevant of 76 PubMed records, and a shared surname and initials can bring in a namesake. All 76 on PubMed
- Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.N Engl J Med · 20191,662 citationsRCR 62.5
- Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.N Engl J Med · 20121,491 citationsRCR 36.1
- 1,432 citationsRCR 46.8
- 1,263 citationsRCR 32.1
- 1,161 citationsRCR 32.0
- A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.N Engl J Med · 2019435 citationsRCR 18.6
- 358 citationsRCR 10.2
- 358 citationsRCR 33.7
- Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial.Ann Oncol · 2023333 citationsRCR 29.6
- Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.Ann Surg Oncol · 2006299 citationsRCR 7.0